The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A prospective descriptive, multi-national, multi-centre observational study of burden of upper GI-symptoms in subjects with cardiovascular risk or disease receiving treatment with low-dose aspirin
- collapse A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of D961H 20 mg and 40 mg once daily oral administration with omeprazole 20 mg once daily oral administration in patients with reflux esophagitis.
- collapse Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
- collapse To assess the efficacy of esomeprazole 20mg once daily in subjects who still had heartburn after receiving rabeprazole
- collapse Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death
- collapse Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
- collapse Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
- collapse Efficacy of Esomeprazole in Patients with Frequent Heartburn
- collapse Efficacy of Esomeprazole in Patients with Frequent Heartburn
- collapse An Open-label, Randomized, Single-center, 2-way Crossover Interaction Study, Evaluating the Effect of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg on the Pharmacodynamics and Pharmacokinetics of Clopidogrel on Days 1 and 9 in Healthy Volunteers.
